139 related articles for article (PubMed ID: 16673870)
1. Complementation assays adapted for DNA repair-deficient keratinocytes.
Fréchet M; Bergoglio V; Chevallier-Lagente O; Sarasin A; Magnaldo T
Methods Mol Biol; 2006; 314():9-23. PubMed ID: 16673870
[TBL] [Abstract][Full Text] [Related]
2. Differential behaviors toward ultraviolet A and B radiation of fibroblasts and keratinocytes from normal and DNA-repair-deficient patients.
Otto AI; Riou L; Marionnet C; Mori T; Sarasin A; Magnaldo T
Cancer Res; 1999 Mar; 59(6):1212-8. PubMed ID: 10096550
[TBL] [Abstract][Full Text] [Related]
3. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.
Magnaldo T; Sarasin A
Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993
[TBL] [Abstract][Full Text] [Related]
4. [The determination of the complementation groups for the cells of patients with xeroderma pigmentosum and the Cockayne syndrome found in Russia].
Pleskach NM; Mikhel'son VM; Raams A; Bootsma D
Tsitologiia; 1996; 38(8):863-8. PubMed ID: 9027016
[TBL] [Abstract][Full Text] [Related]
5. Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus.
Armelini MG; Muotri AR; Marchetto MC; de Lima-Bessa KM; Sarasin A; Menck CF
Cancer Gene Ther; 2005 Apr; 12(4):389-96. PubMed ID: 15650764
[TBL] [Abstract][Full Text] [Related]
6. The cancer-free phenotype in trichothiodystrophy is unrelated to its repair defect.
Berneburg M; Clingen PH; Harcourt SA; Lowe JE; Taylor EM; Green MH; Krutmann J; Arlett CF; Lehmann AR
Cancer Res; 2000 Jan; 60(2):431-8. PubMed ID: 10667598
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients.
Nishiwaki T; Kobayashi N; Iwamoto T; Yamamoto A; Sugiura S; Liu YC; Sarasin A; Okahashi Y; Hirano M; Ueno S; Mori T
DNA Repair (Amst); 2008 Dec; 7(12):1990-8. PubMed ID: 18817897
[TBL] [Abstract][Full Text] [Related]
8. Genetic correction of DNA repair-deficient/cancer-prone xeroderma pigmentosum group C keratinocytes.
Arnaudeau-Bégard C; Brellier F; Chevallier-Lagente O; Hoeijmakers J; Bernerd F; Sarasin A; Magnaldo T
Hum Gene Ther; 2003 Jul; 14(10):983-96. PubMed ID: 12869216
[TBL] [Abstract][Full Text] [Related]
9. Development of a new easy complementation assay for DNA repair deficient human syndromes using cloned repair genes.
Carreau M; Eveno E; Quilliet X; Chevalier-Lagente O; Benoit A; Tanganelli B; Stefanini M; Vermeulen W; Hoeijmakers JH; Sarasin A
Carcinogenesis; 1995 May; 16(5):1003-9. PubMed ID: 7767957
[TBL] [Abstract][Full Text] [Related]
10. Human cancer and DNA repair-deficient diseases.
Sarasin A; Stary A
Cancer Detect Prev; 1997; 21(5):406-11. PubMed ID: 9307843
[TBL] [Abstract][Full Text] [Related]
11. Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes.
Itin PH; Sarasin A; Pittelkow MR
J Am Acad Dermatol; 2001 Jun; 44(6):891-920; quiz 921-4. PubMed ID: 11369901
[TBL] [Abstract][Full Text] [Related]
12. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of UV-induced mutation spectra in human XP-D/ERCC2 gene-mutated xeroderma pigmentosum and trichothiodystrophy cells.
Marionnet C; Benoit A; Benhamou S; Sarasin A; Stary A
J Mol Biol; 1995 Oct; 252(5):550-62. PubMed ID: 7563073
[TBL] [Abstract][Full Text] [Related]
14. Reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro: a model to study hypersensitivity to UV light.
Bernerd F; Asselineau D; Frechet M; Sarasin A; Magnaldo T
Photochem Photobiol; 2005; 81(1):19-24. PubMed ID: 15369409
[TBL] [Abstract][Full Text] [Related]
15. Xeroderma pigmentosum genes: functions inside and outside DNA repair.
Sugasawa K
Carcinogenesis; 2008 Mar; 29(3):455-65. PubMed ID: 18174245
[TBL] [Abstract][Full Text] [Related]
16. Prolonged p53 protein accumulation in trichothiodystrophy fibroblasts dependent on unrepaired pyrimidine dimers on the transcribed strands of cellular genes.
Dumaz N; Duthu A; Ehrhart JC; Drougard C; Appella E; Anderson CW; May P; Sarasin A; Daya-Grosjean L
Mol Carcinog; 1997 Dec; 20(4):340-7. PubMed ID: 9433478
[TBL] [Abstract][Full Text] [Related]
17. Complementation of transformed fibroblasts from patients with combined xeroderma pigmentosum-Cockayne syndrome.
Ellison AR; Nouspikel T; Jaspers NG; Clarkson SG; Gruenert DC
Exp Cell Res; 1998 Aug; 243(1):22-8. PubMed ID: 9716445
[TBL] [Abstract][Full Text] [Related]
18. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G
Cancer Res; 1999 Jul; 59(14):3489-94. PubMed ID: 10416615
[TBL] [Abstract][Full Text] [Related]
19. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany.
Thielmann HW; Popanda O; Edler L; Jung EG
Cancer Res; 1991 Jul; 51(13):3456-70. PubMed ID: 2054785
[TBL] [Abstract][Full Text] [Related]
20. Xeroderma pigmentosum: from genetics to hopes and realities of cutaneous gene therapy.
Magnaldo T
Expert Opin Biol Ther; 2004 Feb; 4(2):169-79. PubMed ID: 14998776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
